Seroatlas · Human Serome Atlas

SSR3

Translocon-associated protein subunit gamma

Also known as: SSRG_HUMAN, TRAPG

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9UNL2
Gene
SSR3
Ensembl
ENSG00000114850
Chromosome
3
Canonical length
185 aa
Protein class
Predicted membrane proteins

OverviewNCBI Gene

The signal sequence receptor (SSR) is a glycosylated endoplasmic reticulum (ER) membrane receptor associated with protein translocation across the ER membrane. The SSR is comprised of four membrane proteins/subunits: alpha, beta, gamma, and delta. The first two are glycosylated subunits and the latter two are non-glycosylated subunits. This gene encodes the gamma subunit, which is predicted to span the membrane four times. [provided by RefSeq, Aug 2010]

Canonical amino-acid sequenceUniProt

185 residues, UniProt reviewed canonical sequence.

>Q9UNL2|SSR3
     1  MAPKGSSKQQ SEEDLLLQDF SRNLSAKSSA LFFGNAFIVS AIPIWLYWRI WHMDLIQSAV
    61  LYSVMTLVST YLVAFAYKNV KFVLKHKVAQ KREDAVSKEV TRKLSEADNR KMSRKEKDER
   121  ILWKKNEVAD YEATTFSIFY NNTLFLVVVI VASFFILKNF NPTVNYILSI SASSGLIALL
   181  STGSK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SSR3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.33
Highest tissue expression
171 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 171 nTPM
  • salivary gland: 170 nTPM
  • epididymis: 165 nTPM
  • cervix: 136 nTPM
  • seminal vesicle: 129 nTPM
  • heart muscle: 109 nTPM

Single-cell type

  • plasma cells: 1,031 nCPM
  • epididymal efferent duct absorptive cells: 697 nCPM
  • extravillous trophoblasts: 636 nCPM
  • gastric progenitor cells: 604 nCPM
  • decidual stromal cells: 587 nCPM
  • epididymal principal cells: 582 nCPM

Immune cell

  • plasmacytoid DC: 163 nTPM
  • non-classical monocyte: 137 nTPM
  • myeloid DC: 116 nTPM
  • basophil: 112 nTPM
  • intermediate monocyte: 104 nTPM
  • MAIT T-cell: 96 nTPM

Brain region

  • white matter: 86 nTPM
  • thalamus: 79 nTPM
  • medulla oblongata: 76 nTPM
  • spinal cord: 73 nTPM
  • hypothalamus: 72 nTPM
  • pons: 64 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SSR3.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 51 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.53
gnomAD pLI
0.75
gnomAD missense Z
0.77
DepMap mean gene effect
-0.03
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Translocon-associated protein subunit gamma
  • Translocon-associated protein, gamma subunit (TRAP-gamma)

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SSR3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SSR3 as an antibody target. Whether an autoantibody or antibody against SSR3 could matter depends on whether native SSR3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SSR3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label SSR3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SSR3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...